Apremilast treatment in patients with psoriatic arthritis leads to favorable changes in body composition and improves disease ...

Medically reviewed by Stella Bard, MD Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...

A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...

Factors associated with multi-b/tsDMARD failure among patients with PsA included female sex, obesity, depression, axial disease, and increased disease activity.

Researchers have established that uveitis (a severe inflammatory eye disease) is bidirectionally linked to psoriatic ...

Among patients with PsA, MetS is associated with certain degenerative changes in the spine and entheses but not with peripheral or axial radiographic damage.

This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...

Psoriatic arthritis combines painful joint inflammation ... creating a dual-symptom disease that requires specialized care. Most people who develop PsA already have psoriasis, though the joint ...